Altamira Therapeutics Company
Altamira Therapeutics is dedicated to developing novel pharmaceutical therapies to protect hearing, silence tinnitus, and restore balance. Altamira Therapeutics is the leading pioneer in the emerging field of therapies for neurotologic disorders affecting the inner ear.
Employee Number:
11-50
Headquarters:
Basel, Basel-Stadt, Switzerland, Europe
Founded Date:
2003-04-01
Industry:
Drug Discovery & Development
Super Industry:
Biopharma & Life Science Tools
Phone Number:
+41 61 201 13 50
Investors:
Hercules Capital, Idinvest Partners, Lacuna, Sofinnova Investments, Sofinnova Partners
Ipo Status:
public
Stock Symbol:
EARS
City:
Basel
Region:
Basel-Stadt
Country:
Switzerland
Founders:
Thomas Meyer




